Ammar Bhatti DO (@AmmarWB) header
Ammar Bhatti DO (@AmmarWB) profile picture

Cardiology Fellow @laheycardiology | Former Lahey IM Chief Resident @bethisraellahey | Alum @UNECOM

Burlington, MA
Joined February 2022
Photo by Ammar Bhatti DO (@AmmarWB)Photo by Ammar Bhatti DO (@AmmarWB)Photo by Ammar Bhatti DO (@AmmarWB)Photo by Ammar Bhatti DO (@AmmarWB)
Thrilled to share our work in #JACC: CardioOnc & be presenting at #GCOS2024! #SGLT2i associated with ⬇️ risk of #CTRCD in patients with cancer and T2DM. A hopeful advance for survivorship & CardioOncology! Thankful to mentors @SarjuGanatraMD @SaurabhSDani bit.ly/4ebDU7t
3
8
28
2,306
Describing the Sex-Specific Distribution of CAC Scores in South Asian Adults in the United States - American College of Cardiology acc.org/Latest-in-Cardiology…
1
8
2
24
5,735
And the journey begins for these fantastic gentlemen! We welcome you ⁦@LaheyCardiology⁩ and look forward to your all round training and transformation as able cardiologists!
7
4
1
91
7,086
Takeaways from #ACC2025. Late breaking trials - take home points @ACCinTouch   1. WARRIOR Trial : Intensive medical therapy did not significantly impact the rate of serious cardiovascular events at five years in women with suspected ischemia with nonobstructive coronary arteries (INOCA).
5
130
3
351
62,594
Ammar Bhatti DO retweeted
#SGLT2i therapy w/ #empagliflozin exerts a dose-dependent cardioprotective effect against AIC. Improved #LVEF was accompanied by enhanced ketone body consumption, improved cardiac energetics, & preserved mitochondrial structure & function jacc.org/doi/10.1016/j.jacca… #JACCCardioOnc
1
19
1
65
7,357
Ammar Bhatti DO retweeted
“Excited to share our latest editorial published in @CircAHA - Our study highlights T1 mapping as a novel marker for heart failure progression in hypertrophic cardiomyopathy (HCM). @EthanRowin @JAHA_AHA @AHAScience
2
5
1
40
3,990
A large review on atrial fibrillation? Don’t mind if I do. Program directors should be printing this out and handing it to all applicable residents. 🎩 tip to the authors. eddyjoemd.com/foamed
3
112
2
473
63,722
I had a fantastic time recording podcast on Heart Disease in South Asians with Rahul Menon of @DiasporaIndian. Listen to this candid but critical conversation here. Special thanks to @khurramn1 @alka_kanaya @jaideeppatelmd @AAgarwalaMD @PSatishMD @pnatarajanmd @RomitB_MD @SarjuGanatraMD @DLBHATTMD youtu.be/nNhvzW1oBRg?si=kXio…
3
15
1
57
6,752
Ammar Bhatti DO retweeted
In this #JACCCardioOnc study, Dr. @AmmarWB, et al highlight that #SGLT2 inhibitors 📉 the risk of CTRCD in pts w/ #T2DM & cancer, as well as lower #heartfailure exacerbations, mortality, & 🏥 jacc.org/doi/10.1016/j.jacca… #CardioOncology #SGLT2i @anita_deswal @AnaBaracCardio @JLiu_MSKCardOn @datsunian @RichardKCheng2 @TeresaLpezFdez @SumanthKhadkeMD @SarjuGanatraMD
2
32
67
8,557
#GLP1RA works for pts with #obesity and #HFpEF Do they work for non-obese (BMI<30) pts with HFpEF?? ✅️THEY DO Among non-obese pts with #Diabetes & #HFpEF GLP-1RA use improved outcomes ⏬️ 🫀failure exacerbation ⏬️ 🏨 hospitalization ⏬️💗 arrhythmia ⏬️ kidney related complications etc sciencedirect.com/science/ar… Study led by our brilliant research fellow @SumanthKhadkeMD in collaboration with @Ashish_Kumar_MD @AmmarWB @SonuAbrahamMD With the guidance from maestro of the field @SaurabhSDani @JavedButler1 @mvaduganathan @gcfmd @anita_deswal @Sadeer_AlKindi @MkosiborodMD @khurramn1 @virani_md et al.
1
12
3
22
7,995
Ammar Bhatti DO retweeted
I am thrilled to share my podcast commentary in JACC:Cardio oncology jacc.org/do/10.1016/1f1abaeb…
1
7
263
Ammar Bhatti DO retweeted
Happy to share our Invited Editorial with @MohamedDabour91 @BlaesAnneMD and @DhariniRamu SGLT2 Inhibitors in Mitigating Cancer Therapy-Related Cardiac Dysfunct... sciencedirect.com/science/ar…
7
13
700
Thrilled to have matched a fantastic group @LaheyCardiology for Cardiology Fellowship 2025! @AmmarWB @BrandonTemelMD @SriramG999 @PawanDagaMD Looking forward to working with you!
6
6
1
109
15,150
Ammar Bhatti DO retweeted
New #JACCHF 📄: bit.ly/40xnSB9 In patients w/ #Obesity, #T2DM & #HFpEF➡️#GLP1 agonists provide incremental benefits in addition to #SGLT2i w/ reduction in: 🔸HF exacerbation 🔸All-cause 🏥 🔸Atrial arrhythmias 🔸AKI 🔸Pulmonary #HTN @rushin311 @SarjuGanatraMD @LaheyResearch
22
2
62
10,894
Ammar Bhatti DO retweeted
New @JACCJournals #JACCHF In patients with #T2DM, ⬆️ #BMI & #HFpEF ➡️ #GLP1 agonists provide incremental benefit in addition to #SGLT2i with ⬇️ in: ▪️HF exacerbation ▪️All cause hospitalization ▪️Atrial arrhythmias ▪️Pulmonary HTN ▪️AKI DOI: 10.1016/j.jchf.2024.07.006
3
22
1
57
7,024
A recent study by @PennThalheimer @mariellesc1 et al. sought to determine whether SGLT2i use is associated with a lower incidence of CTRCD in patients w/ #T2DM & #cancer. Learn more 👉 spr.ly/6016qlXbM #cardiomyopathy #cardiooncology
7
21
1,578
The highest score research abstract @ACCMass comes from @LaheyResearch @LaheyCardiology @LaheyHospital from Bhargav Makwana! Heartiest congratulations and look forward to your successful academic career with us! @SarjuGanatraMD #Microplastics #EDOH @smoffattbruce1
4
8
55
3,782
SGLT2 inhibition may prevent cancer therapy-related cardiac dysfunction and improve other outcomes in patients with diabetes undergoing cancer therapy #GCOS2024 @HemoncToday #CardioOncology @ACCinTouch Read more👇 healio.com/news/cardiology/2…
6
10
1,114